Save the date in your event calendar: Join and learn about the new era of cancer care at the ICPO Theranostics Virtual Summit, Nov 14 -15, 2024
2024年6月27日 - 1:00PM
Save the date in your event calendar:
Join and learn about the new era of cancer care at
the ICPO Theranostics Virtual Summit, Nov 14
-15, 2024
The ICPO Foundation offers a world-class scientific
program powered by academic and industrial experts focusing on
alpha emitters and new radiopharmaceuticals.
June 27, 2024 – Wiesbaden, Germany.
Theranostics combines diagnostics and therapy for precise
cancer treatment. By using tailored radiopharmaceuticals, tumors
can be specifically identified and treated, with high efficacy and
low side effects. This personalized medicine is revolutionizing
oncology. The ICPO Theranostics Summit 2024 takes
place on November 14 to 15, 2024, and will feature a world-class
scientific program powered by over 30 distinguished academic and
industry experts from the ICPO Community. Our focus will be to
explore innovations, from bench to bedside, first in the field of
alpha emitters, with actinium and more, then across the range of
new radiopharmaceuticals, such as FAP and beyond. Moreover, the
objective will be to sketch together the contours of a new era in
cancer care, ultimately benefiting patients around the
globe.
Building on the growing success of the first edition of the ICPO
Theranostics Summit in 2022, as well as of the multiple FAP
(Fibroblast Activation Protein) sessions hosted during the ICPO
Forum in 2023 and the Theranostics World Congress earlier in 2024,
the ICPO Foundation is pleased to launch its new ICPO Theranostics
Summit 2024.
Whether attendees are already very familiar with alpha emitters
and new radiopharmaceuticals or are just curious about how these
latest developments will potentially impact clinical applications
in their country, the ICPO Theranostics Summit 2024 will be very
enlightening. In addition to eye-opening talks and vibrant panel
discussions, there will also be an exciting Q&A session and a
critical debate on the current and future clinical relevance of
radiotheranostics in the perspective of improved patient outcomes
and better access to more personalized, abundant and democratized
cancer care.
Find the program and registration platform here:
www.icpovirtualsummit.com
About ICPO Foundation The International Centers
for Precision Oncology Foundation (ICPO) is a non-profit
organization established in 2019 under German law by leading
international medical practitioners and life sciences
entrepreneurs. Recognizing a paradigm shift in cancer care from one
size fits all to a personalized approach, the ICPO Foundation is
helping to build momentum to scale global patient access to
Radiomolecular Precision Oncology to support this shift. Therefore,
the ICPO Foundation aims to develop an international network of
physical diagnostic and therapeutic Centers for Precision Oncology
organized in a Social Franchise model based on shared know-how,
certified education with the ICPO Academy for Theranostics, and
design and process standardization that enables best clinical
practice globally. Furthermore, it is the ICPO Foundation's
objective to empower its Centers by embedding them in a highly
inclusive Community that spearheads its model and lives up to the
Precision Oncology promise by making it available to all patients
in need, irrespective of country or social status.
Learn more about the ICPO Foundation at www.icpo.foundation and
the ICPO Academy for Theranostics at www.theranostics.academy
Media contact ICPO FoundationSusanne SimonHead
of Communication & CommunityEmail:
susanne.simon@icpo.foundationPhone: + 49 172
8666093www.icpo.foundation
- ICPO Theranostics Virtual Summit 2024